ARTELO BIOSCIENCES, INC. Other Comprehensive Income (Loss), Net of Tax
ARTELO BIOSCIENCES, INC. (ARTL) reported Other Comprehensive Income (Loss), Net of Tax of $4.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-12
- ARTELO BIOSCIENCES, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was $4.00K.
- ARTELO BIOSCIENCES, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was $26.00K.
- ARTELO BIOSCIENCES, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was $5.00K, a 68.75% decline year-over-year.
- ARTELO BIOSCIENCES, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $18.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.00K 10-Q · filed 2026-08-12 | $30.00K 10-Q · filed 2026-08-12 | $35.00K derived: sum of 3 quarters · filed 2026-08-12 | $53.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $26.00K 10-Q · filed 2026-08-12 | $31.00K derived: sum of 2 quarters · filed 2026-08-12 | $49.00K derived: sum of 3 quarters · filed 2026-08-12 | -$19.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $5.00K derived: 8-K 12 month − 10-Q 9 month · filed 2026-03-17 | $23.00K derived: sum of 2 quarters · filed 2026-03-17 | -$45.00K derived: sum of 3 quarters · filed 2026-08-12 | -$70.00K 8-K · filed 2026-03-17 |
| 2025-09-30 | $18.00K 10-Q · filed 2025-11-12 | -$50.00K derived: sum of 2 quarters · filed 2026-08-12 | -$75.00K 10-Q · filed 2025-11-12 | -$59.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$68.00K 10-Q · filed 2026-08-12 | -$93.00K 10-Q · filed 2026-08-12 | -$77.00K derived: sum of 3 quarters · filed 2026-08-12 | -$92.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$25.00K 10-Q · filed 2026-08-12 | -$9.00K derived: sum of 2 quarters · filed 2026-08-12 | -$24.00K derived: sum of 3 quarters · filed 2026-08-12 | -$24.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2024-12-31 | $16.00K derived: 8-K 12 month − 10-Q 9 month · filed 2026-03-17 | $1.00K derived: sum of 2 quarters · filed 2026-03-17 | $1.00K derived: sum of 3 quarters · filed 2026-03-17 | $1.00K 8-K · filed 2026-03-17 |
| 2024-09-30 | -$15.00K 10-Q · filed 2025-11-12 | -$15.00K derived: sum of 2 quarters · filed 2025-11-12 | -$15.00K 10-Q · filed 2025-11-12 | -$19.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 | -$4.00K derived: sum of 3 quarters · filed 2025-08-13 | -$2.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $0.00 8-K · filed 2025-07-11 | -$4.00K derived: sum of 2 quarters · filed 2025-07-11 | -$2.00K derived: sum of 3 quarters · filed 2025-07-11 | $2.00K derived: sum of 4 quarters · filed 2025-07-11 |
| 2023-12-31 | -$4.00K derived: 8-K 12 month − 10-Q 9 month · filed 2025-07-11 | -$2.00K derived: sum of 2 quarters · filed 2025-07-11 | $2.00K derived: sum of 3 quarters · filed 2025-07-11 | $51.00K 8-K · filed 2025-07-11 |
| 2023-09-30 | $2.00K 10-Q · filed 2024-11-12 | $6.00K derived: sum of 2 quarters · filed 2024-11-12 | $55.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $4.00K 10-Q · filed 2024-11-12 | $53.00K 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $49.00K 10-Q · filed 2024-11-12 | |||
| 2022-09-30 | -$212.00K 10-Q · filed 2023-11-13 | -$324.00K derived: sum of 2 quarters · filed 2023-11-13 | -$370.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$112.00K 10-Q · filed 2023-11-13 | -$158.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | -$46.00K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |